Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video chats boost asthma med adherence in young patients

NCT ID NCT03978936

Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether video-based medication coaching helps adolescents and young adults with uncontrolled asthma take their inhaled steroids more regularly. 375 participants received either standard care or telehealth sessions to improve medication use. The goal was to see if coaching leads to better daily adherence and fewer severe asthma attacks over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Medication Therapy Management (MTM) video telehealth coaching
What this could lead to
If it works, this approach could help young people with asthma better manage their condition and have fewer serious asthma attacks.
What could go wrong
This is a completed study, but the intervention is behavioral and results may vary by individual. It does not test a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

375 people

The number who actually took part.

Started

Nov 2019

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 12 through 35 years * Speaks English or Spanish * Physician diagnosed asthma (without any other co-morbid pulmonary disease) * Prescribed ICS treatment for at least 3 months prior to screening * Adherence to Refills and Medication Scale (ARMS) 7-item questionnaire score of \>8 (low or moderate adherence) * Current use of albuterol metered dose inhaler (MDI) for rescue: ProAir, Ventolin, albuterol sulfate (from Prasco or Teva) * Uncontrolled asthma: * Symptomatic asthma defined as 3 of the following in the past 4 weeks: * Daytime symptoms of asthma more than twice per week * Any night awakening due to asthma * Rescue inhaler use for symptoms more than twice per week * Any activity limitation due to asthma; OR * Asthma Control Test score ≤19 * Has iPhone or Android smart phone with Short Message Service (SMS) * Has access to reliable WiFi service and a device with capability for telemedicine study visits * Ability to understand and willingness to sign consent documents * Evidence of Propeller sensor connection in the 4-week run-in period Exclusion Criteria: * Use of an investigational treatment in the previous 30 days. * Previous enrollment in MATCH Structured Interviews ( Aim 1) * Currently enrolled in an intervention trial * Currently uses an ICS not compatible with the Propeller sensor * Inability to comply with study procedures, including: * Inability or unwillingness to provide informed consent (or assent in the case of a minor). * Inability to perform study measurements. * inability to be contacted by phone via calls and /or text messaging * Not willing to have video chat * Any condition(s) in the opinion of the physician that puts the participant at risk from participating in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Uncontrolled asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma bronchial disorder lung disorder obstructive lung disease respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Uncontrolled asthma Young adults

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Children's Mercy Hospital

    Kansas City, Missouri, 64108, United States

  • Columbia University Medical Center

    New York, New York, 10029, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Mount Sinai National Jewish Health Respiratory Institute; Icahn School of Medicine

    New York, New York, 10029, United States

  • National Jewish Medical and Research Center

    Denver, Colorado, 80206, United States

  • Nemours Children's Specialty Care

    Jacksonville, Florida, 32207, United States

  • New York University School of Medicine

    New York, New York, 10016, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Pacific Northwest Airways - VA Puget Sound Healthcare System

    Seattle, Washington, 98108, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Temple University

    Philadelphia, Pennsylvania, 19140, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35249, United States

  • University of Arizona

    Tucson, Arizona, 85724, United States

  • University of California at San Francisco

    San Francisco, California, 94143, United States

  • University of Chicago Hospitals

    Chicago, Illinois, 60637, United States

  • University of Florida College of Medicine

    Jacksonville, Florida, 32209, United States

  • University of Illinois at Chicago

    Chicago, Illinois, 60608, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66103, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109-5360, United States

  • Vermont Lung Center at The University of Vermont

    Colchester, Vermont, 05466, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.